Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PhRMA Close To Agreement With Rep. Tauzin, But Nothing Final

This article was originally published in The Pink Sheet Daily

Executive Summary

Rep. Tauzin will resign from Congress immediately if a contract is finalized. Rules of special election to fill seat could determine timing.

You may also be interested in...



PhRMA Takes A Flier: Marine One Doc Joins Trade Group As Chief Medical Officer

Paul Antony, MD, will be PhRMA’s “chief advocate” on medical policy issues. Antony joins the trade association from the U.S. Navy Presidential helicopter squadron.

PhRMA Takes A Flier: Marine One Doc Joins Trade Group As Chief Medical Officer

Paul Antony, MD, will be PhRMA’s “chief advocate” on medical policy issues. Antony joins the trade association from the U.S. Navy Presidential helicopter squadron.

PhRMA Starts Over In CEO Search After Tauzin Negotiations End

Louisiana Republican breaks off negotiations with trade association amid negative media attention. Rep. Joe Barton will take the helm of the Energy & Commerce Committee.

Related Content

Topics

UsernamePublicRestriction

Register

PS058596

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel